Insiders · Profile

ORTH ANDREW C.

Chief Commercial Officer at Krystal Biotech. Filing since 9 Jun 2023. CIK 0001860010

Company
Date
Role
Action
Shares
Amount
Of holding
9 Jun 2023
Chief Commercial Officer
Sold on a plan
12,500
$1.61M
99.2%
1 decision on file.